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Capsaicin is an organic compound in chili peppers which are consumed by over one quarter of the world's population daily. Studies have
shown that capsaicin can induce apoptosis in some cancer cells by unknown mechanisms. In this study, both gastric cancer and normal epithelial
cells were treated with capsaicin and examined for apoptosis by Annexin V binding. Our results showed that capsaicin induces apoptosis in both
cells, although cancer cells are more susceptible. This susceptibility is dependent on the availability of TRPV6, a calcium-selective channel
protein, as overexpression of TRPV6 in normal cells increased capsaicin-induced apoptosis and knockdown of TRPV6 in cancer cells suppressed
this action. Our results further demonstrated that capsaicin increases mitochondrial permeability through activation of Bax and p53 in a JNK-
dependent manner. Conclusions: (1) TRPV6, rather than TRPV1 (the well-known capsaicin receptor), mediates capsaicin-induced apoptosis in
gastric cells; (2) abundance of TRPV6 in gastric cells determines their live or death under capsaicin treatment; and (3) capsaicin induces apoptosis
by stabilization of p53 through JNK activation. Together, our data suggest that capsaicin may be a promising dietary candidate for cancer
chemoprevention.
Published by Elsevier B.V.Keywords: TRPV6; Capsaicin; Apoptosis; Gastric cancer1. Introduction
Gastric cancer is the second leading cause of cancer-related
deaths in the world. According to the National Cancer Institute,
approximately 760000 cases of gastric cancer are diagnosed
worldwide and more than 22000 cases are diagnosed in the
United States each year. The highest incidence is found in
Japan, South America, Eastern Europe, and parts of the Middle
East. Gastric cancer remains a difficult disease to cure, primarily
because of its aggressiveness and persistence.
A considerable amount of effort has been made to develop
chemoprevention agents (especially those from the human diet)
that selectively kill cancer cells. Hot chili peppers (Capsaicum)
are one of the most heavily and frequently consumed spices
throughout the world. More than one quarter of the world's
population eat chili peppers on a daily basis [1]. Consumption⁎ Corresponding author. Tel.: +1 562 826 8000x5676; fax: +1 562 826 5675.
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doi:10.1016/j.bbamcr.2007.01.001of such spicy foods is increasing in the United States due to
improved transportation and the integration of ethnic dishes into
popular culture. The main component in chili peppers that gives
their heat is capsaicin (C18H27NO3), an organic compound that
was first discovered by L.T. Thresh in 1846 [2]. Since then,
thousands of studies have been done on various aspects of
capsaicin; however, whether it is a carcinogen or an antic-
arcinogen still remains debatable [3,4].
Some studies indicated that chili pepper consumption
induces tumor formation in the gastrointestinal tract of rodents
[5,6]. Consistent with the laboratory results, epidemiological
investigations also showed a higher risk for gastric cancer in
chili pepper consumers, compared with non-consumers [7–9].
However, there has been increasing evidence recently showing
that capsaicin preferentially induces apoptosis in various cancer
cells including skin [10], leukemia [11,12], colon [13], bladder
[14], liver [15], breast [16] and prostate [17], while leaving
normal cells unharmed [12,18,19]. There are also studies
indicating that capsaicin can protect gastric mucosa and
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increasing blood flow [20].
Although capsaicin has been known for more than a
century, its receptor, TRPV1 (or VR1), was not identified until
recently [21]. TRPV1 belongs to the cation channel protein
subfamily TRPV (Transient Receptor Potential Vanilloid)
which currently contains 6 members. TRPV1 predominantly
forms nonselective cation channels in sensory neurons; to a
greatly lesser extent, it is also found in non-neuronal tissues
including gastric epithelial cells [22,23]. Like TRPV1,
TRPV2–4 proteins are mainly found in neurons and smooth
muscle cells. Besides being thermo-receptors, their physiolo-
gical functions remain largely unsubstantiated. Although it is
generally accepted that TRPV1 mediates capsaicin action,
several studies showed TRPV1-independent mechanisms
[17,24]. Unlike TRPV1–4, TRPV5 and TRPV6 are highly
Ca++-selective channel proteins and play major roles in Ca++
uptake in kidney and gastrointestinal tract, respectively
[25,26]. Although stomach is not generally considered to
play a major role in Ca++ absorption and TRPV5 has never
been found in this organ, TRPV6 is expressed greatly in gastric
tissue, especially in glandular cells [26,27]. For this reason, it
has been speculated that TRPV6 existence in gastric epithelial
cells is to maintain the intracellular Ca++ balance after mucus
secretion and to refill the depleted cellular Ca++ stores. More
interestingly, TRPV6 is also found highly elevated in various
cancer tissues including those of the prostate, breast, thyroid,
colon, and ovary [28].
Various mechanisms for capsaicin-induced apoptosis have
been proposed for different cell systems. For example, in
leukemic cells, capsaicin induces apoptosis through activa-
tion of p53 phosphorylation at Serine-15 by reactive oxygen
species [12]; while in prostate cancer cells, capsaicin has
been found to induce apoptosis in a p53-independent manner
[17].
Aims of this study were to determine the effect of capsaicin
on gastric cancer versus normal cells and to explore the
molecular mechanisms behind its action.
2. Materials and methods
2.1. Cell culture
The human gastric cancer AGS cells (American Type Culture Collection,
Manassas, VA) were cultured in RPMI-1640 medium supplemented with 10%
fetal bovine serum (Invitrogen, Carlsbad, CA). The human normal gastric
epithelial cell line GES-1 was obtained from the Cancer Research Institute of
Beijing, China, and maintained in culture in DMEM medium (Invitrogen)
supplemented with 10% fetal bovine serum [29].
2.2. Cell treatment
Capsaicin, capsazepine and 5′-Iodoresiniferatoxin (I-RTX) (Sigma-
Aldrich, Saint Louis, MI) were dissolved in DMSO at 100 mM as stock
solutions and diluted to proper concentrations with culture media right
before treatment. Cells were synchronized in minimum medium with 1%
serum for 24 h before treatment with either DMSO (control) or capsaicin at
indicated concentration and time. To block capsaicin, cells were pretreated
with either 50 μM of capsazepine or 1 and 5 μM of I-RTX (antagonists of
capsaicin).2.3. Transfection
Double-stranded small interfering RNA (siRNA) against TRPV1, TRPV6,
and p53 (Ambion, Austin, TX) had following sequences: TRPV1 (5′-
CUAUAUUCUCCAGCGGGAGTT-3′); TRPV6 (5′-AACCUGCUGCA-
GCAGAAGAGG-3′); and p53 (5′-GCAUGAACCGGAGGCCCAUTT-3′).
A negative oligo (5′-AAUCAUCUAAGCUGGCUUUGC-3′) was used as
control. SiRNA transfection was done 48 h before capsaicin treatment using
siPORT amine transfection agent (Ambion) following the manufacturer's
protocol.
Transfection with plasmid pCMV6-XL4 carrying human TRPV6 cDNA
(OriGene, Rockville, MD) was done using Lipofectamine 2000 reagent
(Invitrogen) following the manufacturer's protocol. Assays were conducted at
least 72 h after transfection.
2.4. Annexin V binding apoptosis assay
Cells (1×105 cells) were plated on cover-glasses and treated with either
vehicle or capsaicin. After treatment, cells were incubated in a binding buffer
containing FITC-conjugated Annexin V and propidium iodide (Abcam,
Cambridge, MA) at room temperature for 5 min in the dark, according to the
manufacturer's protocol. The number of apoptotic cells in 5 microscopic
fields from each of 3 cover-glasses per treatment was recorded under
a Nikon fluorescence microscope (n=15). The apoptotic index (%) was
calculated by dividing the number of apoptotic cells at each time point by
the total number of cells in control (verified by DAPI staining) under the
same magnification.
2.5. Intracellular Ca++ measurement
A Fluo-4 NW Calcium Assay kit (Invitrogen) was used to measure
intracellular Ca++ concentration on NOVOstar Microplate Reader (BMG
Labtech, Offenburg, Germany) following manufacturer's protocols. Briefly,
approximately 5×104 cells per well were grown in a 96-well plate overnight.
The growth medium was replaced next day with 100 μl/well of the Fluo-4
dye solution containing probenecid to prevent extrusion of the dye out of
cells. The plate was incubated at 37 °C for 30 min and then at room
temperature for an additional 30 min. The loaded cells were placed in the
measurement position in the NOVOstar, and the plate containing treatment
reagents was placed in the reagent plate position. The assay was done at
494 nm for excitation and at 516 nm for emission. Before sample injection
three measurements were done to establish the baseline. The Ca++ -rich
solution used contains 140 mM NaCl, 4.7 mM KCl, 1 mM MgCl2, 1.3 mM
CaCl2, and 10 mM HEPES in pH 7.4. Thapsigargin (Sigma-Aldrich), an
intracellular Ca++ pump blocker, was used at 100 nM to deplete intracellular
Ca++ stores.
2.6. Mitochondrial integrity assay
Cells were cultured on cover-glasses and treated with either vehicle or
capsaicin. After treatment, cells were incubated in the MitoCapture reagent
(EMD, San Diego, CA) at 37 °C in a CO2 incubator for 15 min, according to the
manufacturer's protocol. Images were recorded under a Nikon fluorescence
microscope.
To detect cytochrome c leakage, cells were treated with either vehicle or
capsaicin in 100-mm Petri-dishes. After treatment, mitochondrial protein was
separated from cytosolic protein using a cytochrome c release assay kit (EMD)
following the manufacturer's protocol. Equal amount of protein from both
cytosolic and mitochondrial fractions were resolved by Western blotting for
cytochrome c. Cox-IV and β-actin were used as loading controls for mito-
chondrial and cytosolic protein, respectively.
2.7. Immunocytochemistry
Immunocytochemistry was done as described in our previous studies
[30–32] with the following antibodies: TRPV1, TRPV6, p53 (Santa Cruz
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jugated secondary antibodies (Sigma-Aldrich) were used to develop signals.
Images were recorded with a Nikon fluorescence microscope.
2.8. Western blotting and immunoprecipitation
Cells were cultured in 100 mm Petri-dishes and treated with either
vehicle or capsaicin. After treatment, total protein was isolated in a modified
RIPA lysis buffer containing 50 mM Tris–HCl (pH 7.5), 150 mM NaCl,
5 mM EDTA, 0.5% sodium deoxycholate and 1% NP-40. Western blotting
was carried out as described in our previous studies [30–32]. Antibodies
used include TRPV1, TRPV6, p53 and Bax (Santa Cruz Biotechnology),
Bcl-2 (Abcam), TRPV5, c-Jun, ser63-phosphorylated c-Jun, and JNK1
(Millipore, Billerica, MA). Signals were quantified with ImageQuant 5.0
software (GE Healthcare System, Piscataway, NJ) and normalized to the β-
actin levels (Sigma-Aldrich). The experiment was repeated at least three
times.
To examine phosphorylation, 200 μg of each protein extract was first
incubated on a roller with 2 μg of an antibody against each of the in-
dividual protein and 50 μl of Protein-A agarose beads (Sigma-Aldrich) at
4 °C for 2 h. The beads were then washed twice in the lysis buffer and
boiled in 50 μl of protein sample buffer for 5 min. The supernatant was
collected by a brief centrifugation, resolved by Western blotting for
phosphor-serine or phosphor-threonine (BD Biosciences, Franklin Lakes,
NJ).
To assess the stability of p53 protein, cells were pretreated for 1 h with
capsaicin and subsequently incubated for 1, 6, 12 and 24 h with cycloheximide
(Sigma-Aldrich) at 100 μg/ml in the presence or absence of 20 μM SP600125
(Biomol, Plymouth Meeting, PA). Total protein was isolated and analyzed by
Western blotting for p53.
2.9. JNK kinase assay
Equal amount of each protein extract (200 μg) was precipitated with
the antibody against JNK1. The beads were then washed twice in the lysis
buffer and twice in a kinase buffer (25 mM pH 7.5 Tris, 5 mM
β-Glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2) and
followed by an incubation in 50 μl of kinase buffer containing 1 μl of
10 mM ATP (Sigma-Aldrich) and 1 μg of c-Jun protein (Millipore) as a
substrate at 30 °C for 30 min. The beads were then boiled in a protein
sample buffer for 5 min and centrifuged to collect the supernatant. The
samples were analyzed by Western blotting for either JNK1, c-Jun or ser63-
phosphorylated c-Jun.
2.10. Electrophoretic Mobility Shift Assay (EMSA)
EMSA was carried out as described in our previous studies [30–32].
Consensus and mutant oligonucleotides representing p53 response element in
bax gene promoter were synthesized (Retrogen, San Diego, CA) to contain the
following sequences respectively: 5′-TCACAAGTTAGAGACAAGCCTGG-
GCGTGGGCTATATTG-3′ and 5′-TCACAAGTTAGAGATCGCCCTGG-
GCGTGGGCTATATTG-3′.
2.11. Northern blotting
Northern blotting was carried out as described in our previous studies
[30–32]. Oligo probes for p53 (5′-CTCATTCAGCTCTCGGAACATCTCG-
AAGCGCTCACGCCCA-3′) and bax (5′- AGTTGAAGTTGCCGTCAGAA-
AACATGTCAGCTGCCACTCG-3′) were synthesized (Retrogen) and labeled
with γ-32P-ATP (PerkinElmer, Wellesley, MA).
2.12. Statistical analysis
All numerical data are expressed as mean±standard deviation and analyzed
by single classification one-way ANOVA and P<0.05 was considered as
significant.3. Results
3.1. Capsaicin induces more apoptosis in gastric cancer cells
than in normal cells
Capsaicin has been used in a wide range of concentrations,
from 5 μM (e.g. thymocytes) [33] to 1000 μM (e.g. gastric
cancer SNU-1 cells) [34], in various cell systems. To select an
appropriate dose for our study, gastric cancer AGS cells were
first treated with capsaicin at 10 μM, 50 μM and 200 μM for 6 h
and subsequently examined for apoptosis. At all three dosages,
capsaicin induced apoptosis in a dose-dependent manner.
However, capsaicin at 10 μM only induced a mild increase in
apoptosis compared to spontaneous cell death in control, while
at 200 μM also caused a marked increase in necrosis, indicating
its toxicity. At 50 μM capsaicin induced a significant amount of
apoptosis but meantime insignificant in necrosis; therefore, for
the rest of our experiments 50 μM served as the dose unless
indicated otherwise.
To compare the effect of capsaicin on gastric cancer cells
with gastric normal epithelial cells, both AGS and GES-1 cells
were treated with capsaicin at 50 μM for 1, 6 and 24 h. Annexin
V binding assay demonstrated a significant increase in
apoptosis in AGS cells by 8, 20 and 11 fold at 1, 6 and 24 h,
respectively, compared to vehicle-treated control (P<0.001;
Fig. 1A and C). At 1 h, 37±7% of AGS cells showed sign of
early apoptosis, i.e. a green fluorescent membrane staining
(Annexin V) reflecting phosphatidylserine translocation from
the inner side of the cell membrane to the cell surface. At 6 h,
the number of apoptotic cells increased to 85±17%. In addition,
a majority of the apoptotic cells were in the late phase
characterized by red propidium iodide staining in the nucleus
and a halo of green fluorescence on the cell surface (sign of cell
membrane disruption), membrane blebbing, or nuclear frag-
mentation (Fig. 1B). A low apoptosis index was recorded at
24 h, compared to the shorter treatments, due to detachment
after cell death and it was unable to estimate them accurately.
In contrast to AGS cells, GES-1 cells responded to capsaicin
treatment reluctantly. A significant increase in apoptosis was
reached only after incubation with capsaicin for over 24 h,
suggesting that normal gastric epithelial cells might be more
resistant to the apoptotic effect of capsaicin than cancer cells.
3.2. Capsaicin-induced apoptosis in gastric cells is mediated
by TRPV6
Based on numerous studies conducted in neuronal systems
[33,35], capsaicin is traditionally thought to signal through the
receptor TRPV1 (by either induction or phosphorylation). Some
studies showed that TRPV1 is also expressed in gastric
epithelial cells [23]. To determine whether TRPV1 mediates
capsaicin-induced apoptosis in gastric cancer cells, we
examined TRPV1 expression and phosphorylation in AGS
cells after capsaicin treatment. However, we were unable to
detect TRPV1 phosphorylation (data not shown); moreover, its
expression was very low and did not respond to capsaicin
correspondingly either (Fig. 2A). We did not find TRPV5
Fig. 1. Capsaicin induces more apoptosis in cancer cells than in normal cells. (A) Both AGS and GES-1 cells were treated with capsaicin at 50 μM for 1, 6 and 24 h.
Apoptosis was examined by Annexin V binding assay. DAPI staining shows cell density in control at the beginning of the experiment. It should be noted that a low
apoptosis in AGS cells was recorded at 24 h due to detachment of the dead cells. (B) Interpretation of morphological changes in capsaicin-induced cell death under
Annexin V staining. (C) Quantification of capsaicin-induced apoptosis.
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Since TRPV6 is the vanilloid receptor expressed predominantly
in the gut [25,26], we decided to examine the possible
involvement of TRPV6. In response to capsaicin treatment,
TRPV6 expression was increased in a time-dependent manner,
by 105±12%, 221±20% and 352±25% at 1, 6 and 24 h,
respectively (Fig. 2A). When the cells were treated with
capsazepine (a capsaicin antagonist) prior to capsaicin, how-
ever, TRPV6 level remained unchanged and capsaicin failed to
induce apoptosis (Fig. 2B and C). To verify whether TRPV1 is
involved in this process, AGS cells were pretreated with a more
selective TRPV1 antagonist, I-RTX (Fig. 2A). Annexin V
binding assay demonstrated that capsaicin still induced a
significant amount of apoptosis in the presence of I-TRX (Fig.
2B and C), confirming that TRPV1 is not a mediator in
capsaicin-induced apoptosis.
Next, we tested whether capsaicin could still induce
apoptosis if either TRPV1 or TRPV6 is unavailable. AGS
cells were transfected with siRNA against TRPV1 or
TRPV6 for 48 h and subsequently incubated with capsaicin
for an additional 6 h. Knockdown of TRPV1 (TRPV1−) did
not prevent capsaicin-induced apoptosis, however, knock-down of TRPV6 (TRPV6−) reduced it by 72±5% (P<0.01,
Fig. 2B and C), suggesting that TRPV6 is a mediator of
capsaicin-induced apoptosis in gastric cancer cells.
Since TRPV6 is a highly Ca++-selective channel protein,
capsaicin-induced TRPV6 expression might also increase Ca++
influx. To test this hypothesis, we measured intracellular Ca++
concentration using Fluo-4 AM as an indicator before and
after capsaicin treatment. Capsaicin significantly increased
intracellular Ca++ level in AGS cells by 121±17% at the
peak, while knockdown of TRPV6 by siRNA reduced it by
65±8% at baseline and by 58±11% at the peak of capsaicin
treatment (all P<0.001, Fig. 2D). In addition, capsaicin failed
to induce Ca++ influx in the presence of capsazepine. On the
contrary, knockdown of TRPV1 by siRNA did not alter
intracellular Ca++ concentration significantly; neither did I-
RTX pretreatment.
3.3. Overexpression of TRPV6 in GES-1 cells increases
capsaicin-induced apoptosis
In an attempt to understand what makes normal gastric
epithelial cells less sensitive to capsaicin than their cancer
Fig. 2. TRPV6 mediates capsaicin-induced apoptosis. (A) Western blots show that TRPV6 rather than TRPV1 responds to capsaicin treatment in AGS cells and that
capsazepine inhibits this effect. (B) Annexin V binding assay demonstrates that capsaicin-induced apoptosis is dramatically suppressed by either TRPV6 knockdown
(TRPV6−) or capsazepine pretreatment, but remains unchanged when TRPV1 is knocked down (TRPV1−) with siRNA or blocked with I-RTX. Immunocytochemistry
of TRPV1 and TRPV6 verifies the effects of siRNAs on their targets. (C) Quantitative analysis of the effects of siRNA and pharmacological blockers on capsaicin-
induced apoptosis. (D) Intracellular calcium measurement using Fluo-4 demonstrates that capsaicin mobilizes calcium in a TRPV6-dependent manner.
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levels in AGS versus GES-1 cells both before and after
capsaicin treatment. Western blot analysis did not show a
difference in TRPV1 expression between these two cell lines
(Fig. 3A). However, it showed that TRPV6 in AGS cells
was 5 fold higher than it is in GES-1 cells at the baseline
(Fig. 3A). Even after treatment with capsaicin for 6 h,TRPV6 protein level in GES-1 cells was still below the
basal level in AGS cells. Taken together, it is reasonable to
speculate that the susceptibility of gastric cells to capsaicin
might be dependent on the cellular level of TRPV6.
To test this hypothesis, GES-1 cells were transfected with
either a TRPV6 expression plasmid (TRPV6+) or the plasmid
vehicle (control), and then treated with capsaicin for 6 h.
Fig. 3. Overexpression of TRPV6 in GES-1 cells increases capsaicin-induced apoptosis. (A)Western blots show that AGS cells express more TRPV6 than GES-1 cells.
(B) GES-1 cells were transfected with either pCMV-XL4-TRPV6 (TRPV6+) or the plasmid vehicle pCMV-XL4 (control). After 6-h capsaicin treatment, apoptosis in
TRPV6(+) cells was significantly higher than it in control, as demonstrated by Annexin V binding assay (upper panel). Immunocytochemistry of TRPV6 verifies its
overexpression and typical membrane localization (lower panel). (C) Quantitative analysis of apoptosis. (D) Fluo-4 calcium assay demonstrates that overexpression of
TRPV6 in GES-1 cells increases calcium uptake.
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cause more apoptosis at baseline, it increased apoptosis by 4
fold after capsaicin treatment compared to control (P<0.001,
Fig. 3B and C), indicating that the susceptibility of gastric
epithelial cells to the apoptotic effect of capsaicin is
dependent on the abundance of TRPV6. Moreover, Fluo-4
Ca++ assay demonstrated that overexpression of TRPV6 in
GES-1 cells significantly increased intracellular Ca++ con-
centration by 150±23% at baseline (P<0.001, Fig. 3D). To
determine the effect of TRPV6 overexpression on Ca++
uptake, we first removed Ca++ from the incubation buffer and
then added thapsigargin to deplete the intracellular Ca++. Both
actions synchronized intracellular Ca++ to a low level which
was ∼80% lower than TRPV6-transfected cells and ∼50%
lower than control cells. When we reintroduced Ca++(1.3 mM) into the cell culture, the TRPV6-transfected cells
responded with a faster and higher increase of intracellular
Ca++ level than control (Fig. 3D), indicating that over-
expression of TRPV6 in GES-1 cells increases Ca++ channel
function.
3.4. Capsaicin disrupts mitochondrial integrity
It has been shown in other cell types, such as cutaneous
squamous cell carcinoma and leukemic cells, that capsaicin
induces apoptosis through the mitochondrial pathway [10–
14]. To dissect the mechanisms of capsaicin-induced
apoptosis in gastric cancer, we examined the effect of
capsaicin on mitochondrial transmembrane permeability by
incubation of AGS cells with the Mitocapture reagent after
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remains in the mitochondria in form of polymers and gives
off a red fluorescence; however, in case of mitochondrial
damage, the reagent leaks out into cytoplasm as monomers
that generate a green signal. As demonstrated in Fig. 4A, the
red fluorescence in the control AGS cells was rapidly
replaced by green fluorescence under capsaicin treatment.
After 6-h incubation with capsaicin, the red signal was
completely gone. This indicates that capsaicin increases
mitochondrial transmembrane permeability.
As a consequence of mitochondrial permeability increase,
cytochrome c may escape from the mitochondria into
cytoplasm, leading to activation of the caspase cascade. To
determine whether capsaicin causes cytochrome c release in
AGS cells, cell lysates after capsaicin treatment were
fractionated into mitochondrial and cytosolic protein. As
shown in Fig. 4B, a majority of cytochrome c appeared in the
cytosolic fraction after 6-h capsaicin treatment.
3.5. Capsaicin activates p53
Mitochondrial membrane permeability is mainly regulated
by Bcl-2 family proteins, especially Bax (pro-apoptotic) and
Bcl-2 (anti-apoptotic) [36]. In AGS cells capsaicin treatment
increased Bax expression by 4 and 3 fold at 1 and 6 h,
respectively, compared to vehicle-treated control (P<0.001,
Fig. 5A), but did not alter Bcl-2 protein level significantly.
Bax expression is transcriptionally regulated by the tumor
suppressor p53 [37]. Parallel with Bax induction after
capsaicin treatment, we found that p53 protein level was
also dramatically up-regulated by 14 and 9 fold at 1 and 6 h,
respectively (P<0.001, Fig. 5A). To ascertain whether the
Bax induction is through TRPV6-mediated p53 activation,
AGS cells were transfected with siRNA against either p53 or
TRPV6 prior to capsaicin treatment. A negative oligo wasFig. 4. Capsaicin disrupts mitochondrial membrane integrity. (A) AGS cells are stain
under capsaicin treatment. (B) Western blots show that cytochrome c escapes into thused as control. Knockdown of either p53 (p53−) or TRPV6
(TRPV6−) completely abolished capsaicin-induced Bax
expression (Fig. 5A). Annexin V binding assay demonstrated
that capsaicin failed to induce apoptosis when p53 was
knocked down (Fig. 5B). To determine the effect of capsaicin
on p53 transcriptional activity, an in vitro protein binding
assay was performed using the nuclear protein extracts from
the capsaicin treatment and a synthetic oligonucleotide that
represents p53 response element in bax gene promoter.
Capsaicin clearly increased p53 binding activity to this
DNA sequence (Fig. 5C).
As a part of our effort to understand why AGS cells are
more susceptible to capsaicin treatment, both AGS and GES-
1 cells were double-stained for p53 and Cox-IV (a
mitochondrial marker) after capsaicin treatment for 1 h. In
response to capsaicin, AGS cells showed strong nuclear
staining of p53, while GES-1 cells only had a faint p53 signal
(Fig. 5D).
3.6. Capsaicin stabilizes p53 through JNK activation
P53 is a short-lived transcription factor; therefore, its
stability is critical to its transcriptional activity. JNK is known
to be able to phosphorylate p53 at threonine-81 and thereby
increases p53 protein stability and activity [38,39] and acti-
vation of JNK by capsaicin was also reported previously [40].
To determine whether capsaicin activates p53 through JNK in
gastric cells, we first examined the effect of capsaicin on JNK
kinase activity. AGS cells were treated with capsaicin for 1 h. A
kinase assay was performed using recombinant c-Jun protein as
a substrate. Quantification of c-Jun phosphorylation indicated
that capsaicin treatment increased JNK1 activity by 6 fold
(P<0.01; Fig. 6A and B).
Next we attempted to examine whether capsaicin could
still activate p53 if JNK activation was blocked. AGS cellsed with Mitocapture reagent showing an increase in mitochondrial permeability
e cytosolic fraction after capsaicin treatment.
Fig. 5. Capsaicin activates p53. (A) Western blots show that capsaicin increases levels of p53 and Bax in AGS cells; however, knockdown of p53 (p53−)
with siRNA prevented Bax induction, and knockdown of TRPV6 (TRPV6−) prevented both Bax and p53 induction. (B) Annexin V binding assay
demonstrates a dramatic reduction in capsaicin-induced apoptosis by p53 knockdown (p53−). (C) An EMSA demonstrates that capsaicin promotes p53
binding activity to bax gene promoter. Lane 1: free probe; lanes 2, 5, 8, and 11: control protein; lanes 3, 6, 9, and 12: protein from capsaicin treated cells;
lanes 4, 7, 10, and 13: protein from SP600125/capsaicin-treated cells. Lanes 5, 6, and 7 contain anti-p53 antibody; lanes 8, 9, and 10 contain 50-fold excess
unlabeled consensus bax gene promoter sequence; lanes 11, 12, and 13 contain mutant bax gene promoter sequence. (D) Both AGS and GES-1 cells were
double-stained for p53 (FITC) and Cox-IV (TRITC), showing a dramatic nuclear expression of p53 in AGS cells other than in GES-1 cells both before and
after capsaicin treatment.
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inhibitor, before capsaicin treatment. Equal amount of
protein lysates were precipitated with an anti-p53 antibody
and examined for the levels of both total p53 protein and
threonine-phosphorylated p53. Capsaicin treatment increased
both p53 protein content and p53 phosphorylation by a
similar magnitude (∼7 fold) simultaneously (P<0.001; Fig.
6C and D), while inactivation of JNK with SP600125completely abolished both of these actions, suggesting that
capsaicin-induced JNK activation might have stabilized p53
through phosphorylation. This speculation was supported
by EMSA in which SP600125 pretreatment markedly
reduced capsaicin-induced p53 binding activity to DNA
(Fig. 5B).
To further investigate whether capsaicin increases p53
protein content by promoting its stability or by promoting its
Fig. 6. Capsaicin stabilizes p53 protein through activation of JNK in AGS cells. (A and B) JNK kinase assay using recombinant c-Jun protein as a substrate
demonstrates that capsaicin treatment increases JNK activity which can be inhibited by SP600125. (C and D) Immunoprecipitation followed by Western blotting
shows that capsaicin treatment increases p53 phosphorylation (Thr) and total p53 protein content simultaneously but fails to do so when JNK activation is blocked by
SP600125. (E) A Northern blot shows that capsaicin treatment induces bax expression but has no significant effect on p53 mRNA level. (F) Western blots demonstrate
that capsaicin-activated p53 protein becomes unstable in the presence of SP600125. AGS cells were pretreated with capsaicin for 1 h and then incubated with
cycloheximide at 100 μg/ml for 1, 6, 12 and 24 h. (G) Plot of p53 decay is shown as the natural log of the ratio of p53 at indicated time to p53 at time zero. Half-life was
calculated from the slope of a line generated by a least-squares fit numerically.
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levels after capsaicin treatment. Capsaicin clearly induced bax
mRNA expression but did not alter p53 mRNA levels
regardless JNK activity (Fig. 6E), suggesting that capsaicin-
increased p53 protein content is due to protein stabilization
rather than induction of expression.To verify this conclusion, after 1 h of capsaicin treatment,
AGS cells were incubated with cycloheximide (a protein
synthesis inhibitor) for 1, 6, 12 and 24 h in the presence or
absence of SP600125. In the absence of SP600125, the half-
life of p53 was estimated to be 15 h. By contrast, in the
presence of SP600125, p53 protein level was dropped by
574 J. Chow et al. / Biochimica et Biophysica Acta 1773 (2007) 565–57650% within the first hour of incubation with cycloheximide
(Fig. 6F and G), indicating that capsaicin stabilizes p53 by
activation of JNK.
4. Discussion
A majority of previous studies on capsaicin were
conducted in neuronal systems. Based on these studies,
TRPV1 is traditionally thought to be the only mediator for
capsaicin action [1]. During the last decade, dozens of
publications showed that capsaicin has apoptotic effect on
various cell systems. Some of these studies attribute this effect
to activation of TRPV1 [24,33], while others support TRPV1-
independent mechanisms, i.e. capsaicin may act as a
coenzyme Q analogue to interfere mitochondrial respiration,
resulting in generation of reactive oxygen species [10,19]. Our
study provided a new mechanism: capsaicin induces apoptosis
in gastric cancer cells through a different vanilloid receptor,
TRPV6. The relationship between capsaicin and TRPV6 is
largely unknown. One study showed that capsaicin at 250 μM
transiently blocked Ca++ influx in TRPV6-transfected Jurkat
cells [41], while other studies demonstrated that capsaicin
induces Ca++ mobilization [11,43]. Our study showed that
capsaicin induces Ca++ influx in a TRPV6-dependent manner
as knockdown of TRPV6 with siRNA can suppress capsaicin-
induced Ca++ influx and apoptosis. We also demonstrated that
capsaicin-activated TRPV6 expression, Ca++ influx and
consequent apoptosis can be blocked by capsazepine. To our
knowledge, it has never before been reported that capsazepine
affects TRPV6. Capsazepine is known as a competitive
antagonist of capsaicin in its interaction with TRPV1 in
sensory neurons. However, its specificity to TRPV1 is still
questionable. Several studies have reported capsazepine-
insensitive TRPV1 or capsazepine-agonized TRPV1 channels
[42,44], which are consistent with our result. In addition, we
showed that capsaicin can still induce Ca++ influx and
apoptosis after either blockage of TRPV1 with I-RTX (a
specific TRPV1 antagonist) or knockdown with siRNA,
signifying that it is TRPV6 rather than TRPV1 mediating
capsaicin-induced apoptosis in gastric cells.
Several publications described the preferentially deleterious
effect of capsaicin on cancer cells, in contrast to their normal
counterparts [12,19]; however, its mechanisms remain
unknown. Our study provided a possible explanation, at
least for gastrointestinal cancers. We showed that TRPV6 is
expressed more abundantly in gastric cancer AGS cells than it
in normal gastric epithelial GES-1 cells. TRPV6 is a
constitutively active cation channel protein. There is no
indication up to now that TRPV6 requires a stimulus to
become active. Therefore, the availability of this molecule at
the cell surface becomes critical for its function. Consistent
with our result, a previous study showed that TRPV6 is
increasingly expressed in several types of cancer cells
compared to their normal counterparts [28]. Therefore, it is
very likely that high level of TRPV6 might confer gastric
cancer cells susceptibility to capsaicin. This notion was further
supported by our experiment which demonstrated that forcedoverexpression of TRPV6 in GES-1 cells significantly
increased capsaicin-induced apoptosis.
Several studies found that capsaicin increases mitochondrial
permeability [10,11,17,33]; however, different mechanisms
have been proposed. One study showed increases in Bax and
p53 expression after capsaicin treatment and attenuation of
apoptosis by p53 abrogation with siRNA, suggesting a p53-
regulated pathway [12]. This study also attributed the result to
reactive oxygen species-induced p53 phosphorylation at Ser-15.
Another study demonstrated that capsaicin can induce apoptosis
in p53-null prostate cancer cells though it also recognized
inductions in Bax and p53 in p53-expressing cancer cells [17].
Our study showed yet another new mechanism. Here, capsaicin
treatment increased both Bax and p53 protein content, but did
not induce p53 mRNA transcription, suggesting a possible post-
translation mechanism for p53. P53 is a short-lived protein and is
barely detectable in normal growing cells. In cases of cellular
stress, p53 can rapidly become stabilized via various post-
translational modifications including phosphorylation, acetyla-
tion, methylation, and ubiquitination [38]. Among the multiple
phosphorylation sites within p53 protein, JNK-regulated Thr-81
phosphorylation was recently reported to play a critical role in
p53 stability and its transcriptional activity [39]. Here we
demonstrated that capsaicin-induced p53 protein elevation and
its binding activity to DNA can be suppressed by inactivation of
JNK. We also demonstrated that capsaicin increases JNK
activity in parallel with the simultaneous elevation of p53
phosphorylation and total p53 protein content, indicating that a
JNK-regulated p53 phosphorylation stabilizes p53. This notion
was further supported by our p53 protein decay experiment
which demonstrated that inactivation of JNK after capsaicin
treatment shortened p53 half-life by ∼15 fold.
Peppers and pepper-derived products are consumed by more
than a quarter of the world's population every day, although the
amount and the frequency of the consumption vary ethnically
and geographically. According to a report from Mexico [7],
more than half of the population studied eats at least three
jalapeno peppers a day, which is equivalent to ∼30 mg of pure
capsaicin. The stomach surface area of an average human adult is
∼900 cm2, equivalent to the total culture area of 15 Petri-dishes
(100 mm). If we apply 30 mg of capsaicin to 15 dishes of AGS
cells, it would kill them definitely. However, it should be noted
that human body is a much more complex system, an in vitro
dosage is not directly comparable to the amount of capsaicin
uptake by pepper consumers.
Results obtained in this study confirm the anticancer
properties of capsaicin. Although its selectivity in cancer cell
apoptosis is still not fully validated, combining our data with
those of studies from many other investigators suggests that
capsaicin seems to be a promising candidate for cancer
chemoprevention. However, it does not mean that eating large
amounts of peppers would free people from the risk of cancer.
As our study indicated, high doses of capsaicin are toxic, and
may cause cell death not only through apoptosis but also by
necrosis, regardless normal or cancer. More research should
confirm and expand these findings before capsaicin can be
considered for human cancer treatment.
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